High Quality N-Carbethoxy-4-Piperidone - Desmopressin Acetate to Treat central Diabetes Insipidus – Gentolex

Short Description:

Send email to us

Product Detail

Product Tags

Feedback (2)

It is a good way to improve our products and service. Our mission is to develop creative products to customers with a good experience for 2-(4-Hydroxy-6-Methylnicotinamido)-2-(4-Hydroxyphenyl)Acetic Acid, Mercury 1 Acetate, Pharmaceutical, With us your money in safe your business in safe . Hope we can be your trustworthy supplier in China . Looking forward for your cooperation .

High Quality N-Carbethoxy-4-Piperidone - Desmopressin Acetate to Treat central Diabetes Insipidus – Gentolex Detail:

Product Detail

Name	Desmopressin
CAS number	16679-58-6
Molecular formula	C46H64N14O12S2
Molecular weight	1069.22
EINECS Number	240-726-7
Specific rotation	D25 +85.5 ± 2° (calculated for the free peptide)
Density	1.56±0.1 g/cm3(Predicted)
RTECS No.	YW9000000
Storage conditions	Store at 0°C
Solubility	H2O:soluble20mg/mL, clear, colorless
Acidity coefficient	(pKa) 9.90±0.15 (Predicted)

Synonyms

MPR-TYR-PHE-GLN-ASN-CYS-PRO-D-ARG-GLY-NH2; MINIRIN; [DEAMINO1, DARG8] VASOPRESSIN; [DEAMINO-CYS1, D-ARG8]-VASOPRESSIN; DDAVP, HUMAN; DESMOPRESSIN; DESMOPRESSIN, HUMAN; DESAMINO-[D-ARG8] VASOPRESSIN

Indications

(1) Treatment of central diabetes insipidus. After the drug can reduce urinary excretion, reduce urinary frequency and reduce nocturia.

(2) Treatment of nocturnal enuresis (patients aged 5 years or older).

(3) Test the renal urine concentration function, and carry out the differential diagnosis of renal function.

(4) For hemophilia and other bleeding diseases, this product can shorten the bleeding time and prevent bleeding. It can reduce the amount of intraoperative blood loss and postoperative oozing; especially in conjunction with reasonably controlled blood pressure during surgery, it can reduce intraoperative bleeding from different mechanisms, and reduce postoperative oozing, which can play a better role in blood protection.

Treatment of diabetes insipidus

Diabetes insipidus is primarily a disorder of water metabolism characterized by excess urine output, polydipsia, hypoosmolarity, and hypernatremia. Partial or complete deficiency of vasopressin (central diabetes insipidus), or renal insufficiency of vasopressin (nephrogenic diabetes insipidus) can be onset. Clinically, diabetes insipidus is similar to primary polydipsia, a condition in which excessive fluid intake is caused by a malfunction of the regulatory mechanism or abnormal thirst. Contrary to primary polydipsia, the increase in water intake in patients with diabetes insipidus is a corresponding response to changes in osmotic pressure or blood volume.

Product detail pictures:

Related Product Guide:

We thinks what prospects think, the urgency of urgency to act from the interests of a client position of theory, allowing for greater high-quality, reduced processing costs, rates are much more reasonable, won the new and previous consumers the support and affirmation for High Quality N-Carbethoxy-4-Piperidone - Desmopressin Acetate to Treat central Diabetes Insipidus – Gentolex , The product will supply to all over the world, such as: Panama, Comoros, Yemen, We sincerely hope to cooperate with customers all over the world, if you would like to have more information, make sure you kindly contact us, we have been looking forward to building up a great business relationship with you.

2-Bromo-5-Chlorobenzaldehyde